Dutch PM Meets Trump to Prevent Expansion of ASML Export Controls
nashnova research
Dutch PM Rob Jetten says he is 'fairly confident' of a workable deal after multiple rounds of talks with Trump and Congress on the MATCH Act. If passed, the bill would ban all ASML immersion-DUV shipments to China, zeroing out the firm's last major export channel.
What is this meeting about?
Dutch PM Rob Jetten confirmed in a Bloomberg TV interview in New York that he has held multiple rounds of talks with Trump and members of Congress on ASML export controls.
The talks centre on the MATCH Act — a bill that, if passed, would ban ASML from selling any immersion-DUV lithography systems (tools that etch chip circuits with deep-ultraviolet light — less advanced than EUV but still critical to leading-edge production) to China.
This means → the control perimeter would expand from "ban EUV + restrict some DUV" to a blanket DUV ban, closing ASML's last major hardware channel into China.
How does the MATCH Act differ from current rules?
Under the current regime, EUV systems are fully banned from export to China; the Netherlands has also restricted some DUV models, but immersion DUV can still ship.
The MATCH Act would close that gap by pulling immersion DUV into the ban.
In plain terms = today the rule is "the most advanced tools are blocked, the next tier partly blocked." After the Act, it becomes "no advanced tools at all."
How big is ASML's China exposure?
ASML is the world's sole EUV lithography manufacturer and a critical supplier to the current AI-infrastructure build-out, with Europe's largest market capitalisation.
China accounted for 14% of ASML's net system sales in Q2, down from 19% in Q1.
This means → even as the China share shrinks, 14% is still material revenue. If the Act passes, that slice goes to zero.
Can Dutch diplomacy soften the blow?
Jetten's phrasing — "fairly confident" a workable deal can be reached — is positive in tone but offers no specifics on conditions or timeline.
This reflects the Netherlands' core balancing act: cooperate with U.S. security concerns while preserving as much commercial room for ASML as possible — a tightrope walk.
For investors, the key variable has shifted from "will the bill be introduced" to "can diplomacy soften the final terms" — the pivotal node for judging whether ASML's China-revenue risk can be hedged.
市场有风险，内容仅供研究参考，不构成投资建议。